Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

International Journal of Cancer

Volumn 94, Issue 2, 2001, Pages 212-217

  Yoon, Jung Hoon ^a   Dammann, Reinhard ^a   Pfeifer, Gerd P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Colon cancer; CpG island; Methylation; Ovarian cancer; Renal cell carcinoma; Tumor suppressor gene

Indexed keywords

ARTICLE; BREAST CANCER; CHROMOSOME 3P; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUNG CANCER; MOLECULAR CLONING; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CARCINOMA, RENAL CELL; CPG ISLANDS; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0035888160     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1466     Document Type: Article

References (45)

1. Homozygous deletions of human chromosome 3p in lung tumors
2. Accumulation of genetic alterations and progression of primary breast cancer
3. Loss of heterozygosity and p53 gene mutations in breast cancer
4. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer
5. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma
6. Allelotype of renal cell carcinoma
7. Allelic deletions in renal tumors: Histopathological correlations
8. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas
9. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumorigenesis
10. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
11. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes
12. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium
13. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene
14. Epigenefic inactivation of a RAS association family protein from the lung tumor suppressor locus 3p21.3
15. Hypermethylation of the CpG island of RASSF1A, a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
16. Alterations in DNA methylation: A fundamental aspect of neoplasia
17. Cancer epigenetics comes of age
18. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
19. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis
20. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis
21. Inclusion of new microsatellite repeats in allelic loss analysis excludes retention of heterozygosity in the renal cell carcinoma critical region in 3p21
22. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: Analysis of VHL dependent and VHL independent pathways of tumorigenesis
23. Prognostic significance of morphologic parameters in renal cell carcinoma
24. High sensitivity mapping of methylated cytosines
25. COBRA: A sensitive and quantitative DNA methylation assay
26. The VHL tumour-suppressor gene paradigm
27. Silencing of the VHL tumorsuppressor gene by DNA methylation in renal carcinoma
28. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation
29. Novel mutations of the von Hippel-Lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type
30. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
31. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
32. Hypermethylation of the hMLH 1 promoter in colon cancer with microsatellite instability
33. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
34. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma
35. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
36. CpG island methylator phenotype in colorectal cancer
37. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
38. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brainand other human cancers
39. p16/MTS1 inactivation in ovarian carcinomas: High frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors
40. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
41. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer
42. BRCA1 promoter region hypermethylation in ovarian carcinoma: A population-based study
43. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas
44. Identification of Norel as a potential Ras effector
45. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis